Innovative AI Platform Savana's proprietary deep-tech AI infrastructure leverages Clinical NLP and machine learning to transform unstructured health data into strategic insights, offering a compelling value proposition for healthcare providers and pharma companies seeking advanced data analytics.

Growing Financial Backing With recent funding of 25 million USD led by prominent venture firms, Savana has demonstrated strong investor confidence, signaling potential for expansion and increased deployment of their AI solutions across new markets and client segments.

Partnership Opportunities Existing collaborations with organizations like the COPD Foundation highlight Savana’s capability to develop targeted applications in disease identification and management, presenting opportunities to partner on bespoke healthcare analytics and diagnostic tools.

Health Data Focus Specializing in extracting value from Electronic Medical Records and clinical trial data, Savana can address the needs of hospitals, regulators, and pharmaceutical companies looking to optimize clinical workflows and accelerate drug development through real-world evidence.

Market Expansion Potential Having secured initial Series B funding to expand from Spain into the US market, Savana is positioned for increased outreach, offering scalable AI solutions that can meet the demands of increasingly digitized healthcare systems globally.